Back to catalogue
№ 302 40 filings · 2021-07-26 → 2026-07-28

ROCKWOOD STRATEGIC PLC

RKW
Financial Services Share price 323p Market cap £202m Overall fit 380 /1000

High-quality investment trust trading near NAV with an outstanding track record and net cash, but a poor fit for the investor's specific mandate: AI exposure is only indirect via a few underlying holdings (notably Filtronic), operating leverage at the RKW level is minimal (it is a fee-based trust, not an operating company), and the stock offers ~0% upside to NAV, so there is no valuation cushion to compound the AI thesis.

Fair value range 290p–340p Mid case · £191m
Absolute upside -5.2% vs current market cap
Conviction 4/5 confidence in fair call
Supports the call
  • Fair value anchored by audited, frequently-published NAV
  • Manager has independently verified No.1 UK small-cap IT track record over 3 and 5 years
  • Trust structure eliminates operating-company forecasting risk
Limits the call
  • Concentrated portfolio (top 10 = 59% of NAV) can move sharply on single-name events
  • Premium/discount to NAV can shift with UK small-cap sentiment
Methodology

NAV-based valuation with modest premium range

In one line · bull case

A top-tier concentrated UK small-cap investment trust with a proven engaged-value manager, growing NAV and net cash, priced at essentially NAV.

In one line · biggest risk

Concentration means a single portfolio blow-up (as with Argentex or Hostmore) can materially dent NAV, and the shares carry compounding UK small-cap sentiment risk on top of underlying portfolio risk.

Drivers
AI beneficiary 30 /100
Indirect only — Filtronic (SpaceX ground stations), Tribal (HE SaaS) and Kooth are the AI-adjacent holdings; the trust itself is not an AI receiver.
Operating leverage 25 /100
Fee/admin fixed costs give modest scale benefits as NAV grows but the trust is not an operating-leverage vehicle.
Earnings vs expectations 70 /100
Consistently exceeds 15% IRR target and beats relevant indices on rolling 3/5-year basis.
Growth momentum 70 /100
NAV grew 200% over three years to March 2026 and issuance continues at premium to NAV.
Moat 40 /100
Manager reputation, engaged-investor track record, and IT structure give a moderate but non-structural edge.
Earnings quality 80 /100
Clean IT accounting under IAS 34 with unqualified audits; NAV is Level 1 marked from quoted prices for essentially the whole book.
Management quality 80 /100
Richard Staveley/Harwood have delivered top-decile returns with candid, transparent reporting and personal alignment.
Cyclicality 55 /100
Exposure runs through concentrated UK small-cap positions, many of which are industrial and financial cyclicals.
Leverage 10 /100
Net cash on the balance sheet, no borrowings, fortress balance sheet.

ROCKWOOD STRATEGIC PLC (RKW) — Investment Research Note

Executive summary

Rockwood Strategic is a UK-listed investment trust (Main Market, LSE) managed by Rockwood Asset Management (formerly Harwood Capital), running a concentrated, engaged, "value + recovery" strategy in sub-£250m UK small-caps. Over the five years to March 2026 NAV total return is +97.4% versus the FTSE AIM All-Share at −40.1% — the best performing UK equity investment trust over that period per the AIC. The single most important point for valuation today: RKW is an investment trust whose value is anchored by its published NAV (~312p as at 12 June 2026); the shares trade at a small discount to NAV and the AI thesis is at best indirect, via a handful of portfolio holdings (Filtronic, Kooth, Tribal).

Fair value estimate

  • Methodology: NAV-based valuation (only appropriate approach for a closed-end investment trust). Cross-checked against the manager's post-period-end NAV updates and portfolio marks.
  • Anchor: NAV per share was 266.44p at 31 March 2026 and 311.64p at 12 June 2026 (announced 17 June 2026 2026-06-17 full year). Post-period the fund also disclosed takeover offers for Treatt (+48%) and Van Elle (+58.5%) and a further +69% move in Filtronic — all NAV-accretive but partly already reflected in the June mark.
  • Fair value range: 290p – 340p per share, implying a market cap range of £176m – £207m. The low end assumes the mark reverses somewhat as recent post-period gains settle; the high end allows a modest (~5%) premium to spot NAV to reflect the manager's demonstrated ability to compound at >15% IRR, which historically has justified periods of premium-to-NAV pricing (the shares averaged a 2.9% premium in FY25 and issued new stock at a premium through both FY25 and FY26).
  • Midpoint: c.315p / £191m market cap.
  • Current price 316p / market cap £191.6mabsolute upside of roughly 0% (range −8% to +8%). The stock is trading essentially at fair value; it is neither cheap nor expensive on the NAV alone.

Sector context

  • Sector: Financials / Financial Services (ICB) — but functionally this is a closed-end UK small-cap investment trust, not an operating financial. Sector benchmarks are AIC UK Smaller Companies peers.
  • Quality vs. peers: Above typical peers on performance (No.1 in AIC UK Small Companies over 3 and 5 years), balance sheet (net cash, no gearing) and disclosure. Fees are competitive (1.0% mgmt + 10% performance over 6% hurdle, subject to caps).
  • Listed peers: Odyssean Investment Trust (OIT), Aberforth Smaller Companies (ASL), River UK Micro Cap. Rockwood is smaller and more concentrated (24 holdings, top 10 = ~59% NAV) than most peers.

Investment thesis

  • Best-in-class manager track record with a differentiated engaged/activist approach: 200% NAV growth in three years, No.1 UK small companies IT over 3 and 5 years, with a strategy that reliably converts value opportunities into realised returns via engagement, board changes, and takeovers (Galliford Try +48% IRR, Treatt +48% bid premium, Van Elle +58.5% premium, Filtronic +69% post-period) 2026-06-17 full year.
  • Portfolio contains identifiable AI-adjacent optionality without the AI premium: Filtronic (RF components into SpaceX/Starlink ground stations & LEO satellites) has been transformational, and Tribal Group (Higher Education SaaS) and Kooth (mental-health platform with proprietary US-state contracts) provide additional though modest AI-adjacent exposure 2025-11-18 half-year. You get this exposure at NAV, not at a growth-stock multiple.
  • Growing scale, premium-to-NAV issuance, and index inclusion (FTSE All-Share, FTSE Small Cap) — self-reinforcing: broader universe, lower cost ratios, more liquid shares, and post-year end further net issuance took NAV to £180m by 12 June 2026 2026-06-17 full year.

Key risks

  • Concentration risk: top 10 = 59% of NAV, and idiosyncratic blow-ups have hurt (Argentex written off in H1 26; Hostmore ~99% loss in FY25) 2025-11-18 half-year, 2025-06-18 full year. In a concentrated fund a single event can materially dent NAV.
  • UK small-cap and AIM structural headwinds: sustained retail outflows, AIM tax-break cuts, weak IPO market, "soggy" domestic economy; the manager repeatedly flags this backdrop and depends on takeover activity to crystallise value 2025-11-18 half-year, 2025-06-18 full year.
  • Valuation risk vs NAV and macro shocks: In March 2026 NAV was noticeably dented by "US military action against Iran" — a stark reminder that the concentrated equity book can move sharply on macro/geopolitical events, and the small premium/discount to NAV can widen quickly 2026-06-17 full year.

Operating leverage

For an investment trust, "operating leverage" is muted and largely fee-driven. Fixed overheads (director fees, admin, custody) total c.£0.5m–£1m annually; the ongoing charges ratio was 1.66% annualised at H1 26 and would fall further as NAV scales, because the management fee is now capped such that total fees do not exceed 3% of NAV, and fixed overhead does not scale with NAV 2025-11-18 half-year. Practical upside: on NAV growing from ~£180m to, say, £250m, the ongoing charge ratio would compress by perhaps 15-25bps — worth having but not a value driver. The real "operating leverage" here is portfolio-level: several holdings (Trifast, RM, Capita, James Fisher, M&C Saatchi, Filtronic) are themselves margin-recovery stories where the manager quantifies 3-10 percentage points of operating margin uplift potential 2025-06-18 full year — but that leverage accrues to the underlying companies, not to RKW's own P&L.

Value-trap signals

None identified. The fund has a growing NAV, a small premium/discount rather than a persistent deep discount, strong external validation (multiple awards, index inclusion), net cash on the balance sheet, and a manager with material personal ownership.

Earnings vs. expectations

An investment trust does not "guide" or have a consensus in the same way as an operating company. What is measurable is NAV vs. the manager's own 15% IRR target and vs. relevant indices:

  • FY24: NAV TR +5.1% (below target, but ahead of FTSE AIM −8.6%) 2024-06-19 full year.
  • FY25: NAV TR +21.0% (well ahead of target) 2025-06-18 full year.
  • H1 FY26: NAV TR +12.5% in 6 months (well ahead) 2025-11-18 half-year.
  • FY26: NAV TR +7.1% for the year (impacted by March Iran shock) but +17% in the ~2.5 months post period-end 2026-06-17 full year. Overall pattern: consistent outperformance of relevant indices and, on a rolling 3-5 year basis, comfortably ahead of the 15% IRR target.

Conviction

4 — high. Anchoring factors: (1) valuation is anchored by an audited, listed-equity NAV published monthly, so the fair value range is unusually tight; (2) the manager's track record is well-documented and independently verified (AIC rankings); (3) the trust's own market cap sits very close to NAV so the arithmetic is simple. Limiting factors: (i) NAV is portfolio-mark dependent, and a concentrated book can move sharply in weeks; (ii) any premium/discount to NAV can shift with sentiment toward UK small-caps, adding a second layer of price variability that is genuinely hard to forecast.

Filings consulted · 41

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-07-28Result OF Agm2026-07-28_9691801_result-of-agm.md0.30
  2. 2026-07-03Posting OF Annual Report And Notice OF Agm2026-07-03_9652683_posting-of-annual-report-and-notice-of-agm.md0.95
  3. 2026-06-17Full Year Results TO 31 March 20262026-06-17_9621795_full-year-results-to-31-march-2026.md1.00
  4. 2026-05-08Investor Presentation2026-05-08_9558250_investor-presentation.md0.70
  5. 2025-11-18Half Year Financial Report2025-11-18_9239817_half-year-financial-report.md0.77
  6. 2025-10-13Investor Presentation Via Investor Meet Company2025-10-13_9165869_investor-presentation-via-investor-meet-company.md0.59
  7. 2025-10-02Trading Update2025-10-02_9145138_trading-update.md0.72
  8. 2025-06-26Posting OF Annual Report And Notice OF Agm2025-06-26_8950628_posting-of-annual-report-and-notice-of-agm.md0.62
  9. 2025-06-18Full Year Results TO 31 March 20252025-06-18_8934714_full-year-results-to-31-march-2025.md0.65
  10. 2025-05-12Investor Presentation Via Investor Meet Company2025-05-12_8871375_investor-presentation-via-investor-meet-company.md0.46
  11. 2025-04-14Trading Update2025-04-14_8828179_trading-update.md0.55
  12. 2024-11-19Interim Results2024-11-19_8557940_interim-results.md0.58
  13. 2024-10-03Trading Update2024-10-03_8459005_trading-update.md0.55
  14. 2024-09-23Investor Presentation Via Investor Meet Company2024-09-23_8431219_investor-presentation-via-investor-meet-company.md0.46
  15. 2024-07-31Result OF Agm2024-07-31_8341539_result-of-agm.md0.14
  16. 2024-07-01Dividend Declaration2024-07-01_8288156_dividend-declaration.md0.14
  17. 2024-06-28Posting OF Annual Report And Notice OF Agm2024-06-28_8285418_posting-of-annual-report-and-notice-of-agm.md0.43
  18. 2024-06-19Full Year Results TO 31 March 20242024-06-19_8266553_full-year-results-to-31-march-2024.md0.45
  19. 2024-05-16Investor Presentation Via Investor Meet Company2024-05-16_8200028_investor-presentation-via-investor-meet-company.md0.32
  20. 2023-11-22Interim Results2023-11-22_7895704_interim-results.md0.41
  21. 2023-11-09Investor Presentation Via Investor Meet Company2023-11-09_7869884_investor-presentation-via-investor-meet-company.md0.32
  22. 2023-10-04Trading Update2023-10-04_7794878_trading-update.md0.38
  23. 2023-09-12Result OF Agm2023-09-12_7751032_result-of-agm.md0.14
  24. 2023-07-07Posting OF Annual Report And Notice OF Agm2023-07-07_7618186_posting-of-annual-report-and-notice-of-agm.md0.24
  25. 2023-06-22Full Year Results TO 31 March 20232023-06-22_7587545_full-year-results-to-31-march-2023.md0.25
  26. 2023-05-31Investor Presentation Via Investor Meet Company2023-05-31_7551438_investor-presentation-via-investor-meet-company.md0.17
  27. 2023-04-11Trading Update2023-04-11_7459906_trading-update.md0.21
  28. 2022-11-23Interim Results2022-11-23_7456479_interim-results.md0.23
  29. 2022-11-22Notice OF Results And Investor Presentation2022-11-22_7454107_notice-of-results-and-investor-presentation.md0.17
  30. 2022-10-07Trading Update2022-10-07_7252482_trading-update.md0.21
  31. 2022-09-20Investor Presentation2022-09-20_7369309_investor-presentation.md0.17
  32. 2022-09-14Result OF Agm2022-09-14_7314112_result-of-agm.md0.07
  33. 2022-08-19Posting OF Annual Report And Notice OF Agm2022-08-19_7131631_posting-of-annual-report-and-notice-of-agm.md0.24
  34. 2022-06-23Full Year Results TO 31 March 20222022-06-23_7067281_full-year-results-to-31-march-2022.md0.25
  35. 2022-05-04Change OF Name Amp Investment Advisory Group Launch2022-05-04_7145619_change-of-name-amp-investment-advisory-group-launch.md0.15
  36. 2022-05-04Change OF Name Amp Investment Advisory Group Launch2022-05-04_7191488_change-of-name-amp-investment-advisory-group-launch.md0.15
  37. 2021-12-22Change OF Name And Tidm2021-12-22_6914929_change-of-name-and-tidm.md0.15
  38. 2021-12-08Interim Results2021-12-08_6756182_interim-results.md0.23
  39. 2021-10-15Announcement RE Strategic Review And Requisition2021-10-15_6814804_announcement-re-strategic-review-and-requisition.md0.24
  40. 2021-10-11Conclusion OF Strategic Review2021-10-11_6759572_conclusion-of-strategic-review.md0.24
  41. 2021-07-26Result OF Agm2021-07-26_6743531_result-of-agm.md0.03

This research note was authored by a large language model after reading 40 regulatory filings published between 2021-07-26 and 2026-07-28. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.